This week’s Weekend Reads, which appears below, was preempted yesterday by the news that the Office of Research Integrity had issued a finding of misconduct in the long-running case of Anil Potti. The week also featured news about a child psychiatry trial halted for unexplained reasons, and saw the launch of our new weekly column at STAT, a new life sciences site from Boston Globe Media. Here’s what was happening elsewhere: Continue reading Weekend reads: Elsevier mutiny; babies as co-authors; what to do after rejection
Category: weekend reads
Weekend reads: Psychology stats errors abound; font choice dooms grant application
This week at Retraction Watch featured high-profile retractions from Nature and the BMJ. Here’s what was happening elsewhere: Continue reading Weekend reads: Psychology stats errors abound; font choice dooms grant application
Weekend reads, part 2: Pressure to publish limits innovation; Frontiers a predatory publisher?
Lots of good reads elsewhere this week. As promised yesterday, here’s part 2: Continue reading Weekend reads, part 2: Pressure to publish limits innovation; Frontiers a predatory publisher?
Weekend reads, part 1: Pirating paywalled papers; a sex scandal and fudged data at Stanford
The week at Retraction Watch featured a lot of movement on our leaderboard, with a new total for Diederik Stapel, and a new entry. It also featured a lot going on elsewhere, so here’s part I of Weekend Reads (we’ll have more tomorrow morning): Continue reading Weekend reads, part 1: Pirating paywalled papers; a sex scandal and fudged data at Stanford
Weekend reads: Angry meta-analysts; imposter cell lines; when things go wrong
This week at Retraction Watch featured nine more fake peer review retractions, this time from Elsevier, and an update to the retraction count for one-time record holder Joachim Boldt. Here’s what was happening elsewhere: Continue reading Weekend reads: Angry meta-analysts; imposter cell lines; when things go wrong
Weekend reads: FDA nominee authorship questions; low economics replication rates
The week at Retraction Watch featured a mysterious retraction from PLOS ONE, and a thoughtful piece by a scientist we’ve covered frequently on where we went wrong in that coverage. Here’s what was happening elsewhere: Continue reading Weekend reads: FDA nominee authorship questions; low economics replication rates
Weekend reads, part 2: Criminalizing scientific fraud; Nobel Prize folly; boosting impact factor
There were so many items to choose from this week for Weekend Reads — probably because it was Peer Review Week — that we decided to split them into two posts. Here’s part 2: Continue reading Weekend reads, part 2: Criminalizing scientific fraud; Nobel Prize folly; boosting impact factor
Weekend reads, part 1: Editor slams PubPeer; scientific fraud pays off
The week at Retraction Watch featured yet another case of fake peer review, and a court sentence for a Danish researcher found to have committed fraud. Here’s what was happening elsewhere (stay tuned for part 2 tomorrow): Continue reading Weekend reads, part 1: Editor slams PubPeer; scientific fraud pays off
Weekend reads: STAP saga over once and for all?; plagiarizing prof gets tenure
The week at Retraction Watch featured the appeal of a modern-day retraction, and a look at whether a retraction by a Nobel Prize winner should be retracted 50 years later. Here’s what was happening elsewhere: Continue reading Weekend reads: STAP saga over once and for all?; plagiarizing prof gets tenure
Weekend reads: Country retraction rankings; social psychology department replication rankings
This week at Retraction Watch featured an ironic case of what doesn’t make a journal great, and the retraction of a paper from JAMA. Here’s what was happening elsewhere: Continue reading Weekend reads: Country retraction rankings; social psychology department replication rankings